Guideline of guidelines: non-muscle-invasive bladder cancer.

Item

http://www.wikidata.org/entity/Q39069660

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Guideline of guidelines: non-muscle-invasive bladder cancer.

@en

Guideline of guidelines: non-muscle-invasive bladder cancer.

@nl

type

Item

label

Guideline of guidelines: non-muscle-invasive bladder cancer.

@en

Guideline of guidelines: non-muscle-invasive bladder cancer.

@nl

prefLabel

Guideline of guidelines: non-muscle-invasive bladder cancer.

@en

Guideline of guidelines: non-muscle-invasive bladder cancer.

@nl

P1476

Guideline of guidelines: non-muscle-invasive bladder cancer.

@en

P2093

Aditya Bagrodia

http://www.w3.org/2001/XMLSchema#string

Solomon L Woldu

http://www.w3.org/2001/XMLSchema#string

P2860

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).

Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Car

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review.

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.

Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis.

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis.

Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.

P304

371-380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJU.13760

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Yair Lotan

P577

2017-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28058776

http://www.w3.org/2001/XMLSchema#string

P932

5315602

http://www.w3.org/2001/XMLSchema#string